Good news! A newly-developed drug cocktail could lead to cure of diabetes

Related image

While many issues can manage to take a toll on you in life,there are those carrying those burdens plus physical health complications in addition,more than stressful right?

Well to ease some of these pain,researchers give their best and time to find to find cures to the many life threatening diseases.

And to some good news,  a newly-developed drug cocktail makes insulin-producing cells multiply – a discovery that could lead to a cure for diabetes, researchers claim.

Image result for beta-cells images

People with diabetes have a shortage of beta-cells, which make insulin. Without enough insulin, they are unable to properly process glucose.

The team, from the Icahn School of Medicine at Mount Sinai Hospital in New York, had already discovered that a drug called harmine could supercharge the pancreas cells to make 10 times more insulin-making beta cells a day.

What’s more, when harmine was given in combination with a second drug – normally used to boost bone-growth – 40 times more beta cells formed a day.

Image result for congrats gifs

The drug is experimental and in early stages of testing, but the researchers think that its powerful effect on insulin-producing cells could be a game-changer in the treatment of both type 1 and type 2 diabetes.

According to the Centers for Disease Control and Prevention, 30.3 million Americans – about 9.4 percent of the population – suffers from diabetes.

Related image

Another estimated 84 million are living with prediabetes, a condition that can lead to type 2 diabetes within five years if left untreated.

Diabetes occurs when there are too few beta cells in the pancreas to produce insulin or when they produce very little insulin, the hormone needed to get glucose from the bloodstream into cells.

When left untreated, diabetes can result in serious health complications such as kidney damage, eye damage, heart disease, stroke and even vision loss.

Leave a Reply

Your email address will not be published. Required fields are marked *